Arthur Krieg to Antibodies, Monoclonal, Murine-Derived
This is a "connection" page, showing publications Arthur Krieg has written about Antibodies, Monoclonal, Murine-Derived.
Connection Strength
0.017
-
Leonard JP, Link BK, Emmanouilides C, Gregory SA, Weisdorf D, Andrey J, Hainsworth J, Sparano JA, Tsai DE, Horning S, Krieg AM, Weiner GJ. Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma. Clin Cancer Res. 2007 Oct 15; 13(20):6168-74.
Score: 0.017